bioAffinity Technologies, Inc.
BIAF- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001712762
No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $782.5K in total; no superinvestor holds it.
Other share classesBIAFW
13F holders, Q2 2025
Institutional positions in bioAffinity Technologies, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +1 vs. Q1 2025
- Shares held
- 362.3K
- −96.2K (−21.0%) vs. Q1 2025
- Total value
- $104.0K
- −$14.3K (−12.1%) vs. Q1 2025
- New holders
- 6
- 4 more added
- Sold out
- 5
- 3 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIAF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $782.5K |
| Q1 2026 | 14 | $928.5K |
| Q4 2025 | 9 | $92.5K |
| Q3 2025 | 12 | $823.7K |
| Q2 2025 | 17 | $104.0K |
| Q1 2025 | 17 | $132.3K |
| Q4 2024 | 16 | $497.4K |
| Q3 2024 | 14 | $973.0K |
| Q2 2024 | 17 | $863.3K |
| Q1 2024 | 14 | $484.4K |
| Q4 2023 | 12 | $230.5K |
| Q3 2023 | 10 | $139.7K |
| Q2 2023 | 7 | $177.0K |
| Q1 2023 | 6 | $193.5K |
| Q4 2022 | 5 | $133.5K |
| Q3 2022 | 6 | $192.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding bioAffinity Technologies, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 125,459 | $36.0K | 0.00% | +6,770+5.7% | Added |
| Allworth Financial LP | 53,734 | $15.4K | 0.00% | +53,734 | New |
| Vanguard Group Inc | 40,642 | $11.7K | 0.00% | −136,255−77.0% | Reduced |
| Captrust Financial Advisors | 27,885 | $8.01K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 25,000 | $7.18K | 0.00% | +10,000+66.7% | Added |
| State Street Corp | 17,600 | $5.05K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 15,598 | $4.48K | 0.00% | +2,990+23.7% | Added |
| StoneX Group Inc. | 15,206 | $4.37K | 0.00% | +15,206 | New |
| Northern Trust Corp | 13,662 | $3.92K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 12,095 | $3.47K | 0.00% | 00.0% | Unchanged |
| Sprott Inc. | 10,000 | $2.87K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 3,128 | $898 | 0.00% | −13−0.4% | Reduced |
| Citigroup Inc | 1,478 | $424 | 0.00% | +1,478 | New |
| Raymond James Financial Inc | 500 | $144 | 0.00% | +500 | New |
| Bank of America Corp | 205 | $58 | 0.00% | +117+133.0% | Added |
| Morgan Stanley | 100 | $29 | 0.00% | −200−66.7% | Reduced |
| UBS Group AG | 24 | $7 | 0.00% | +24 | New |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −22,500−100.0% | Sold out |
| Van Hulzen Asset Management, LLC | 0 | $0 | 0.00% | −16,012−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,841−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −3,181−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Sheaff Brock Investment Advisors, LLC | – | – | – | – | Not filed |